News | Radiation Therapy | January 15, 2016

ASTRO Pledges Support for President’s Commitment to Cancer Research

Society applauds initiative announced in State of the Union address

January 15, 2016 — The American Society for Radiation Oncology (ASTRO) applauded President Obama and Vice President Biden for the “moonshot” effort in cancer research announced in the President’s State of the Union speech on Tuesday.

ASTRO pledged its support of the initiative to bolster resources and foster collaboration among the oncology research community, as well as Vice President Biden’s call in October 2015 to “end cancer as we know it today.”

Despite a two-decade span of decline in cancer death rates, the disease remains a leading source of morbidity and mortality for Americans. The American Cancer Society estimates that nearly 1.7 million Americans will receive cancer diagnoses in 2016, including one in three women and one in two men.

More than half of cancer patients undergo radiation therapy at some point in their treatment, either alone or in conjunction with other treatment options. Existing research demonstrates the effectiveness of radiation therapy as well as its potential in combination with other treatments. ASTRO supports the President’s request to bolster research initiatives that encompass the full range of multidisciplinary therapies in the quest to eradicate cancer.

ASTRO supports research, education and professional training to improve care and outcomes for cancer patients. In 2015 alone, the society provided scientists nearly $1 million through grants and awards supporting radiation oncology research. ASTRO also publishes three medical journals and hosts a variety of scientific meetings in an effort to advance cancer science and help the field avoid the “silos” cautioned in Vice President Biden’s statement, ultimately with the goal of improving patient lives.

For more information: www.astro.org

Related Content

Videos | Radiation Therapy | February 21, 2019
ITN Associate Editor Jeff Zagoudis speaks with Christy Kesslering, M.D., medical director of radiation oncology at th
FDA Clears Advancements for Viewray MRIdian Radiation Therapy System
Technology | Image Guided Radiation Therapy (IGRT) | February 21, 2019
February 21, 2019 — ViewRay Inc. received 510(k) clearance from the U.S.
Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...